|Bid||13.46 x 34100|
|Ask||13.59 x 3200|
|Day's Range||13.43 - 13.66|
|52 Week Range||12.94 - 18.86|
|Beta (5Y Monthly)||1.48|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 10, 2021|
|Forward Dividend & Yield||0.44 (3.22%)|
|Ex-Dividend Date||Aug 23, 2021|
|1y Target Est||20.15|
Here's why they selected Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Viatris (NASDAQ: VTRS). Prosper Junior Bakiny (Regeneron Pharmaceuticals): Shares of Regeneron dropped like a rock amid September's broad market declines.
In this article, we will discuss the top 10 stock picks of James Morrow’s Callodine Capital. If you want to skip our detailed analysis of Morrow’s history, investment philosophy, and hedge fund performance, go directly to James Morrow’s Callodine Capital Portfolio: Top 5 Picks. Callodine Capital Management is the investment arm of the Callodine Group, […]
Despite the enhanced market volatility that investors have been seeing lately, there's still no shortage of excellent stocks to buy. Brian Withers: As the market goes topsy turvy and goes red or whatever, what's one stock that's off of its high that you think is a good value today? Demitri Kalogeropoulos: Sure, I will offer Stitch Fix (NASDAQ: SFIX) as a potential, you might want to add to your watch list if you haven't been watching this.